Journal profile · CARDIAC & CARDIOVASCULAR SYSTEMS

JACC-Heart Failure

ISSN 2213-1779 · eISSN 2213-1787 · Elsevier BV · UNITED STATES

JACC-Heart Failure: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 11.79; hybrid open access; APC about USD 5,000; median 83 days to acceptance (98 articles, last 24 months); 432 articles in 2025; indexed in SCIE and Scopus.

Impact factor11.79Latest value listed by LetPub
CAS zoneZone 1 · Medicine2025 upgraded edition, major category · Top journal · 2026 Xinrui edition Zone 1 · Medicine
Review time83 daysMedian, submission to acceptance · 98 articles, last 24 months · PubMed
APCUSD 5,000Hybrid journal: charged only for open-access articles
Acceptance—No reports yet
Articles per year4322025 · OpenAlex count

Scope

Aims, scope and focus

JACC-Heart Failure is published by Elsevier BV and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors and Mechanical Circulatory Support Devices, together about 48.7% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)

A Journal of the American College of CardiologyJACC: Heart Failure is one of a family of specialist journals launched by the renowned Journal of the American College of Cardiology (JACC) . It publishes the most important findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal of the Journal is to improve our understanding of the disease, clinical trial, clinical outcomes, and advances in therapies through timely, insightful scientific communication. The Journal embraces interdisciplinary relationships with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery as they relate to heart failure. In addition, the Journal includes articles concerning pharmacogenetics, biomarkers, and metabolomics.

From the journal's Aims & Scope

Research area (LetPub): CARDIAC & CARDIOVASCULAR SYSTEMS

Editor-in-chief Biykem BozkurtPublisher website

Editorial board by country: 2 in mainland China (about 1%); most named United States 159, Canada 9, United Kingdom 6, Italy 6, Türkiye 6 (218 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Heart Failure Treatment and ManagementMedicine23.8%
  2. Cardiovascular Function and Risk FactorsMedicine17.6%
  3. Mechanical Circulatory Support DevicesEngineering7.3%
  4. Cardiac pacing and defibrillation studiesMedicine5.9%
  5. Cardiac Structural Anomalies and RepairMedicine5%
  6. Diabetes Treatment and ManagementMedicine4.3%
  7. Cardiovascular and exercise physiologyMedicine3.7%
  8. Transplantation: Methods and OutcomesMedicine3.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorCardiac & Cardiovascular SystemsZone 1

Top journal: yesReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorCardiac & Cardiovascular SystemsZone 1

Top journal: yesReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorCardiac & Cardiovascular SystemsZone 1

Top journal: yesReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEPubMedPublisher website

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
11.79LetPub ·
Impact factor (publisher)
11.9Publisher website ·
CiteScore 2026-06
16LetPub ·
CiteScore (publisher)
16Publisher website ·
SJR 2026-06
4.04LetPub ·
SNIP 2026-06
3.13LetPub ·
h-index
46LetPub ·
h-index
144OpenAlex ·
i10-index
1,168OpenAlex ·
2-year mean citedness
4.51OpenAlex ·
Self-citation rate
5%LetPub ·
Share of gold OA articles
27.78%LetPub ·

Volume

Articles per year
137LetPub ·

Articles by year OpenAlex count · 3,080 in total · the current year is incomplete

YearArticlesOpen accessCitations
202623989127
20254323041,514
20243092962,781
20233583575,091
20221671673,904
20211731734,484

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

83 daysMedian, submission to acceptance · P25–P75 32 days – 123 days

Acceptance to online
median 42 days (92 articles)
Submission to online
median 129 days
Sample
98 articles with submission and acceptance dates (710 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Peer review
Single anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 5,000 / EUR 4,680 / GBP 4,000 / JPY 620,150——
Publisher websiteUSD 5,250——

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare6 items from the author guidelines
Abstract
≤ 250 words
Manuscript length
≤ 7,500 words
Reference style
AMA
Suggested reviewers
Optional
Highlights
Required
Cover letter
Required
Publisher website · model-extracted, each line checked against the text
Article types accepted13, with length limits
  1. commentaryThere will be two types of submissions for Commentary articles: 1) Leading Edge Commentary and 2) Early Career Corner:Leading Edge Commentary. These articles wi…main text ≤ 3,000 words · references ≤ 10
  2. editorialAll Editorial Comments published in JACC: Heart Failure are invited by the Editors. If you are invited to write an editorial, specific requirements will be sent…main text ≤ 1,500 words
  3. editorial commentsEditorial CommentsLength not stated
  4. implementation perspectives ("how to" corner)Implementation Perspectives ("How To" Corner)Length not stated
  5. letterand/or emerging investigators. Research Letters should be ≤1,000 words (including text, references, and figure legend). Abstract:main text ≤ 1,000 words
  6. letters to the editorWe welcome formal comments on articles published in JACC: Heart Failure. Letters to the Editor will be considered for publication only if they pose a clearly st…main text ≤ 400 words · references ≤ 5
  7. letters to the editor and repliesLetters to the Editor and RepliesLength not stated
  8. methodology and mechanisms cornerMethodology and Mechanisms CornerLength not stated
  9. original research papersOriginal Research PapersLength not stated
  10. research lettersResearch LettersLength not stated
  11. reviewThese submissions will provide a focused review of an important area that can adequately be covered in a relatively succinct format, as compared with State-of-t…main text ≤ 3,000 words · abstract ≤ 150 words
  12. review topic of the monthReview Topic of the MonthLength not stated
  13. state of the art reviewsState of the Art ReviewsLength not stated
Publisher website
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, License & copyright, Open access, Peer review, Plagiarism, Preprints
Authorship Authorship

Each author must have contributed significantly to the submitted work. If there are more than 4 authors, the contribution of each author must be substantiated in the cover letter. If authorship is attributed to a group (either solely or in addition to 1 or more individual authors), all members of the group must meet the full criteria and requirements for authorship. Each individual author should b…

Source ↗Publisher website ·
Conflicts of interest Disclosure of AI Programs

Relationship with industry disclosure policy Model summary

Please disclose in the cover letter and in the acknowledgement section (the latter of which is published, if the paper is accepted) if any artificial intelligence (AI) programs (e.g., ChatGPT, or other similar software) contributed to the compilation of the submitted manuscript as well as the nature of the contribution that the tool provided. This could include design, performance, analysis, writi…

Source ↗Publisher website ·
License & copyright CC BY for Funded Authors Only

Elsevier has established a number of agreements with funding bodies, which allow authors to comply with their funder's open access policies. Some funding bodies will reimburse the author for the Open Access Publication Fee. Details of existing agreements are available online.After acceptance, open access papers will be published under a noncommercial license. For authors requiring a commercial CC …

Source ↗Publisher website ·
Open access Open Access

Please visit our Open Access page for more information about open access publishing in this journal.

Source ↗Publisher website ·
Peer review Review Process

Exclusive submission policy Model summary

JACC: Heart Failure uses a single-blind peer-review system, meaning that the authors are blinded to the identity of the reviewers and as a general rule, although there are exceptions, the reviewers are blinded to each other. While the JACC: Heart Failure Associate Editor will be identified at the end of the review process, all correspondence concerning a manuscript should be addressed to the JACC:…

Source ↗Publisher website ·
Plagiarism Plagiarism

The Office of Research Integrity (ORI) defines plagiarism as "theft or misappropriation of intellectual property and the substantial unattributed textual copying of another's work." Manuscripts where unacknowledged copying of others' ideas, language and/or results will not be published in JACC Journals and, depending on level of egregiousness, will be reported to ORI and/or other agencies. Therefo…

Source ↗Publisher website ·
Preprints Preprint References

Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Elsevier BV
Country or region
UNITED STATES
Language
English
ISSN
2213-1779
Electronic ISSN
2213-1787
Official links

FAQ

Frequently asked questions about JACC-Heart Failure

What CAS zone is JACC-Heart Failure in?

In the 2025 upgraded edition of the CAS Journal Ranking, JACC-Heart Failure is in Zone 1 of Medicine, and in Zone 1 of the minor category Cardiac & Cardiovascular Systems; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of JACC-Heart Failure?

The latest impact factor listed by LetPub is 11.79; CiteScore 16, h-index 144.

How long does peer review take at JACC-Heart Failure?

Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 83 days (interquartile range 32–123 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of JACC-Heart Failure?

According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 7,500 words; Reference style: AMA; Suggested reviewers: Optional; Highlights: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of JACC-Heart Failure based?

Of the 218 board members whose country the journal's board page names, 2 (about 1%) are in mainland China; the countries named most often are United States (159), Canada (9) and United Kingdom (6). Counted from the institutions listed on the board page; for reference only.

Which databases index JACC-Heart Failure?

According to LetPub and DOAJ records, JACC-Heart Failure is indexed in SCIE and Scopus. The journal's website also lists MEDLINE and PubMed; that list has not been checked against each database.

Is JACC-Heart Failure open access, and what is the APC?

JACC-Heart Failure is a hybrid journal. For open-access publication: APC about USD 5,000.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .